Zolinza, the most recent skin cancer drug has today received approval from the U.S. Food and Drug Administration (FDA). Zolinza (vorinostat) capsules is mainly recommended// for the treatment of cutaneous T-cell lymphoma (CTCL) type of skin cancer when the disease persists, worsens, or returns during or after treatment with other medicines.
Zolinza has been approved as part of FDA's Orphan Drug program that offers companies financial incentives to develop medications for diseases which affect less than 200,000 American patients a year. About three in every one million people are diagnosed with CTCL each year in the United States. Most of those afflicted with CTCL are men with an average age of 50 years.
Steven Galson, M.D., director of FDA's Center for Drug Evaluation and Research said, "This approval is another example of the benefits of modern research that's focused on providing prescribers with safe and effective therapies for all types of cancer, including those that affect relatively few patients."
Two clinical trials that were conducted with 107 CTCL patients gave evidence of Zolinza's safety and effectiveness. These patients were treated with Zolinza following return of their disease following other treatments.
30 percent of patients who received Zolinza observed an improvement in a scale that was defined by scoring of skin lesions and lasted an average of 168 days.
Some of the most common serious adverse events that occurred were pulmonary embolism, deep vein thrombosis, dehydration, and anemia. Some of most common other adverse events were gastrointestinal symptoms such as nausea, diarrhea, vomiting, anorexia and constipation; fatigue; chills; and taste disorders.
However Zolinza has shown probable fetal harm if administered during pregnancy according to results of animal studies.
Zolinza is manufactured by Pantheon, Inc., in Mississauga, Ontario, Canada, for Merck & Co., Inc., Whitehouse
NLA Related medicine news :1
. Groundbreaking Study Gives Hope For Patients With Kidney Cancer 2
. Gene Therapy Gives Hope For Patients With Muscular Dystrophy3
. Statins Gives New Hope for Increased Survival Rate of Heart Failure Patients4
. US Doctors Association Gives away $110,000 To NGO’5
. Woman In Coma Gives Birth To Daughter6
. Artificial Heart , Gives Hope For Patients Awaiting a Heart Transplant 7
. New Eye Surgery Gives Hope To Short-Sighted 8
. Jharkhand Gives Health industry status 9
. WHO Gives Its Approval For Bird Flu Test Kit10
. FDA Gives Its Approval For Inhaler11
. Congestion for Use of Clarinex-D 12 Hour cleared – FDA Gives the No